Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

September 01, 1994; Volume 22,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Amann, M T

    1. You have access
      The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

B

  1. Bai, S A

    1. You have access
      Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
      S M Lankford, C Maskasame and S A Bai
      Drug Metabolism and Disposition September 1994, 22 (5) 776-787;
  2. Baker, G B

    1. You have access
      Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
      R T Coutts, O O Bolaji, P Su and G B Baker
      Drug Metabolism and Disposition September 1994, 22 (5) 756-760;
  3. Bolaji, O O

    1. You have access
      Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
      R T Coutts, O O Bolaji, P Su and G B Baker
      Drug Metabolism and Disposition September 1994, 22 (5) 756-760;
  4. Burcham, D L

    1. You have access
      Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;
  5. Buters, J T

    1. You have access
      cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;

C

  1. Cepa, S P

    1. You have access
      The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;
  2. Chang, T K

    1. You have access
      1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
      T K Chang, H Chen and D J Waxman
      Drug Metabolism and Disposition September 1994, 22 (5) 673-679;
  3. Charkowski, D M

    1. You have access
      Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;
  4. Charman, W N

    1. You have access
      Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
      N L Pochopin, W N Charman and V J Stella
      Drug Metabolism and Disposition September 1994, 22 (5) 770-775;
  5. Chen, H

    1. You have access
      1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
      T K Chang, H Chen and D J Waxman
      Drug Metabolism and Disposition September 1994, 22 (5) 673-679;
  6. Chen, I W

    1. You have access
      Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
      I W Chen and J H Lin
      Drug Metabolism and Disposition September 1994, 22 (5) 693-699;
  7. Chiu, S H

    1. You have access
      FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
      B V Karanam, S H Vincent, D J Newton, R W Wang and S H Chiu
      Drug Metabolism and Disposition September 1994, 22 (5) 811-814;
  8. Coffman, B

    1. You have access
      Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;
  9. Coutts, R T

    1. You have access
      Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
      R T Coutts, O O Bolaji, P Su and G B Baker
      Drug Metabolism and Disposition September 1994, 22 (5) 756-760;

D

  1. Dekant, W

    1. You have access
      Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
      U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
      Drug Metabolism and Disposition September 1994, 22 (5) 667-672;
  2. Dow, J

    1. You have access
      Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
      J Dow, F Piriou, E Wolf, B D Dulery and K D Haegele
      Drug Metabolism and Disposition September 1994, 22 (5) 738-749;
  3. Dulery, B D

    1. You have access
      Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
      J Dow, F Piriou, E Wolf, B D Dulery and K D Haegele
      Drug Metabolism and Disposition September 1994, 22 (5) 738-749;

F

  1. Ferrero, J L

    1. You have access
      The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;
  2. Fujimaki, M

    1. You have access
      Oxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.
      M Fujimaki
      Drug Metabolism and Disposition September 1994, 22 (5) 700-708;

G

  1. Gal, J

    1. You have access
      Stereoselective hydroxylation of tacrine in rats and humans.
      W D Hooper, W F Pool, T F Woolf and J Gal
      Drug Metabolism and Disposition September 1994, 22 (5) 719-724;
  2. Garvey, D S

    1. You have access
      The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;
  3. Gescher, A

    1. You have access
      Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.
      M B Hargreaves, B C Jones, D A Smith and A Gescher
      Drug Metabolism and Disposition September 1994, 22 (5) 806-810;
  4. Gonzalez, F J

    1. You have access
      cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;
  5. Goto, M

    1. You have access
      Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;
  6. Green, M D

    1. You have access
      Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.
      M D Green, E M Oturu and T R Tephly
      Drug Metabolism and Disposition September 1994, 22 (5) 799-805;
  7. Gregus, Z

    1. You have access
      Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;
  8. Grubb, M F

    1. You have access
      Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;
  9. Guenthner, T M

    1. You have access
      Detoxication of the 2',3'-epoxide metabolites of allylbenzene and estragole. Conjugation with glutathione.
      G Luo and T M Guenthner
      Drug Metabolism and Disposition September 1994, 22 (5) 731-737;

H

  1. Haegele, K D

    1. You have access
      Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
      J Dow, F Piriou, E Wolf, B D Dulery and K D Haegele
      Drug Metabolism and Disposition September 1994, 22 (5) 738-749;
  2. Hardwick, J P

    1. You have access
      cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;
  3. Hargreaves, M B

    1. You have access
      Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.
      M B Hargreaves, B C Jones, D A Smith and A Gescher
      Drug Metabolism and Disposition September 1994, 22 (5) 806-810;
  4. Hashizaki, M

    1. You have access
      Carbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.
      K Tajima, M Hashizaki, K Yamamoto and T Mizutani
      Drug Metabolism and Disposition September 1994, 22 (5) 815-818;
  5. Hijioka, T

    1. You have access
      Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;
  6. Hirobe, M

    1. You have access
      Inter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.
      E Takahara, O Nagata, H Kato, S Ohta and M Hirobe
      Drug Metabolism and Disposition September 1994, 22 (5) 761-769;
  7. Hooper, W D

    1. You have access
      Stereoselective hydroxylation of tacrine in rats and humans.
      W D Hooper, W F Pool, T F Woolf and J Gal
      Drug Metabolism and Disposition September 1994, 22 (5) 719-724;
  8. Huang, S M

    1. You have access
      Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;

J

  1. Jones, B C

    1. You have access
      Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.
      M B Hargreaves, B C Jones, D A Smith and A Gescher
      Drug Metabolism and Disposition September 1994, 22 (5) 806-810;

K

  1. Karanam, B V

    1. You have access
      FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
      B V Karanam, S H Vincent, D J Newton, R W Wang and S H Chiu
      Drug Metabolism and Disposition September 1994, 22 (5) 811-814;
  2. Kato, H

    1. You have access
      Inter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.
      E Takahara, O Nagata, H Kato, S Ohta and M Hirobe
      Drug Metabolism and Disposition September 1994, 22 (5) 761-769;
  3. Kauffman, F C

    1. You have access
      Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;
  4. Kawazoe, S

    1. You have access
      Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.
      T Mizutani, K Yoshida and S Kawazoe
      Drug Metabolism and Disposition September 1994, 22 (5) 750-755;
  5. Kerssebaum, R

    1. You have access
      Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
      U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
      Drug Metabolism and Disposition September 1994, 22 (5) 667-672;
  6. Kim, H J

    1. You have access
      Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;
  7. Klaassen, C D

    1. You have access
      Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;
  8. Korzekwa, K R

    1. You have access
      cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;
  9. Köster, U

    1. You have access
      Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
      U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
      Drug Metabolism and Disposition September 1994, 22 (5) 667-672;
  10. Kunze, K L

    1. You have access
      cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;

L

  1. Lankford, S M

    1. You have access
      Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
      S M Lankford, C Maskasame and S A Bai
      Drug Metabolism and Disposition September 1994, 22 (5) 776-787;
  2. Lin, J H

    1. You have access
      Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
      I W Chen and J H Lin
      Drug Metabolism and Disposition September 1994, 22 (5) 693-699;
  3. Liu, Y

    1. You have access
      Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;
  4. Luo, G

    1. You have access
      Detoxication of the 2',3'-epoxide metabolites of allylbenzene and estragole. Conjugation with glutathione.
      G Luo and T M Guenthner
      Drug Metabolism and Disposition September 1994, 22 (5) 731-737;

M

  1. Machinist, J M

    1. You have access
      The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;
  2. Madhu, C

    1. You have access
      Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;
  3. Maskasame, C

    1. You have access
      Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
      S M Lankford, C Maskasame and S A Bai
      Drug Metabolism and Disposition September 1994, 22 (5) 776-787;
  4. McQuade, R D

    1. You have access
      Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;
  5. Mizutani, T

    1. You have access
      Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.
      T Mizutani, K Yoshida and S Kawazoe
      Drug Metabolism and Disposition September 1994, 22 (5) 750-755;
    2. You have access
      Carbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.
      K Tajima, M Hashizaki, K Yamamoto and T Mizutani
      Drug Metabolism and Disposition September 1994, 22 (5) 815-818;

N

  1. Nagata, O

    1. You have access
      Inter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.
      E Takahara, O Nagata, H Kato, S Ohta and M Hirobe
      Drug Metabolism and Disposition September 1994, 22 (5) 761-769;
  2. Newton, D J

    1. You have access
      FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
      B V Karanam, S H Vincent, D J Newton, R W Wang and S H Chiu
      Drug Metabolism and Disposition September 1994, 22 (5) 811-814;

O

  1. Ohta, S

    1. You have access
      Inter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.
      E Takahara, O Nagata, H Kato, S Ohta and M Hirobe
      Drug Metabolism and Disposition September 1994, 22 (5) 761-769;
  2. Oide, H

    1. You have access
      Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;
  3. Omata, Y

    1. You have access
      cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;
  4. Oturu, E M

    1. You have access
      Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.
      M D Green, E M Oturu and T R Tephly
      Drug Metabolism and Disposition September 1994, 22 (5) 799-805;

P

  1. Piriou, F

    1. You have access
      Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
      J Dow, F Piriou, E Wolf, B D Dulery and K D Haegele
      Drug Metabolism and Disposition September 1994, 22 (5) 738-749;
  2. Pochopin, N L

    1. You have access
      Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
      N L Pochopin, W N Charman and V J Stella
      Drug Metabolism and Disposition September 1994, 22 (5) 770-775;
  3. Pool, W F

    1. You have access
      Stereoselective hydroxylation of tacrine in rats and humans.
      W D Hooper, W F Pool, T F Woolf and J Gal
      Drug Metabolism and Disposition September 1994, 22 (5) 719-724;

Q

  1. Quon, C Y

    1. You have access
      Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;

R

  1. Rios, G

    1. You have access
      Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;
  2. Rodrigues, A D

    1. You have access
      The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;
  3. Rotert, G A

    1. You have access
      The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;
  4. Rozman, P

    1. You have access
      Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;

S

  1. Saxton, P L

    1. You have access
      Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;
  2. Smith, D A

    1. You have access
      Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.
      M B Hargreaves, B C Jones, D A Smith and A Gescher
      Drug Metabolism and Disposition September 1994, 22 (5) 806-810;
  3. Speerschneider, P

    1. You have access
      Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
      U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
      Drug Metabolism and Disposition September 1994, 22 (5) 667-672;
  4. Stella, V J

    1. You have access
      Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
      N L Pochopin, W N Charman and V J Stella
      Drug Metabolism and Disposition September 1994, 22 (5) 770-775;
  5. Styczynski, P

    1. You have access
      Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;
  6. Su, P

    1. You have access
      Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
      R T Coutts, O O Bolaji, P Su and G B Baker
      Drug Metabolism and Disposition September 1994, 22 (5) 756-760;
  7. Sullivan, J P

    1. You have access
      The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;
  8. Surber, B W

    1. You have access
      The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

T

  1. Tajima, K

    1. You have access
      Carbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.
      K Tajima, M Hashizaki, K Yamamoto and T Mizutani
      Drug Metabolism and Disposition September 1994, 22 (5) 815-818;
  2. Takahara, E

    1. You have access
      Inter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.
      E Takahara, O Nagata, H Kato, S Ohta and M Hirobe
      Drug Metabolism and Disposition September 1994, 22 (5) 761-769;
  3. Tedford, C E

    1. You have access
      Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;
  4. Tephly, T R

    1. You have access
      Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;
    2. You have access
      Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.
      M D Green, E M Oturu and T R Tephly
      Drug Metabolism and Disposition September 1994, 22 (5) 799-805;
  5. Thurman, R G

    1. You have access
      Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;
  6. Tich, N R

    1. You have access
      The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

V

  1. Vanrollins, M

    1. You have access
      Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;
  2. Vincent, S H

    1. You have access
      FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
      B V Karanam, S H Vincent, D J Newton, R W Wang and S H Chiu
      Drug Metabolism and Disposition September 1994, 22 (5) 811-814;

W

  1. Wang, R W

    1. You have access
      FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
      B V Karanam, S H Vincent, D J Newton, R W Wang and S H Chiu
      Drug Metabolism and Disposition September 1994, 22 (5) 811-814;
  2. Waxman, D J

    1. You have access
      1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
      T K Chang, H Chen and D J Waxman
      Drug Metabolism and Disposition September 1994, 22 (5) 673-679;
  3. Wittmann, H

    1. You have access
      Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
      U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
      Drug Metabolism and Disposition September 1994, 22 (5) 667-672;
  4. Wolf, E

    1. You have access
      Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
      J Dow, F Piriou, E Wolf, B D Dulery and K D Haegele
      Drug Metabolism and Disposition September 1994, 22 (5) 738-749;
  5. Wong, Y N

    1. You have access
      Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;
  6. Woolf, T F

    1. You have access
      Stereoselective hydroxylation of tacrine in rats and humans.
      W D Hooper, W F Pool, T F Woolf and J Gal
      Drug Metabolism and Disposition September 1994, 22 (5) 719-724;

Y

  1. Yamamoto, K

    1. You have access
      Carbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.
      K Tajima, M Hashizaki, K Yamamoto and T Mizutani
      Drug Metabolism and Disposition September 1994, 22 (5) 815-818;
  2. Yoshida, K

    1. You have access
      Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.
      T Mizutani, K Yoshida and S Kawazoe
      Drug Metabolism and Disposition September 1994, 22 (5) 750-755;

Z

  1. Zhong, Z

    1. You have access
      Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 22, Issue 5
1 Sep 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics